Patents by Inventor Jason L. Larabee

Jason L. Larabee has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Peptide inhibitors of clostridium difficile toxin B (TcdB) toxin
    Patent number: 10709758
    Abstract: Disclosed are synthetic peptides and peptide compositions, including peptide conjugates, that can ameliorate and/or block the cytotoxicity of Clostridium difficile toxin B(TcdB), and methods of their use for inhibiting the activity of Clostridium difficile toxin B(TcdB) and protecting against damage during Clostridium difficile toxin B(TcdB) disease, and/or for use as cell penetrating peptides for enhancing the delivery of particular heterogenous molecules into cells.
    Type: Grant
    Filed: September 2, 2016
    Date of Patent: July 14, 2020
    Assignee: The Board of Regents of the University of Oklahoma
    Inventors: Jimmy D. Ballard, Jason L. Larabee
  • PEPTIDE INHIBITORS OF CLOSTRIDIUM DIFFICILE TCDB TOXIN
    Publication number: 20180243365
    Abstract: Disclosed are synthetic peptides and peptide compositions, including peptide conjugates, that can ameliorate and/or block the cytotoxicity of C. difficile TcdB toxin, and methods of their use for inhibiting the activity of TcdB and protecting against damage during C. difficile disease, and/or for use as cell penetrating peptides for enhancing the delivery of particular heterogenous molecules into cells.
    Type: Application
    Filed: September 2, 2016
    Publication date: August 30, 2018
    Inventors: JIMMY D. BALLARD, Jason L. Larabee